About 28 Trademarks found that are owned by Simulations Plus Inc.

GASTRO PLUS

Computer software, namely, computer software for modeling cellular response to a drug or chemical for use in the fields of pharmaceutical, medical, or preclinical research; computer software for conducting simulations of cellular bioenergetics in response to a drug or chemical for use in the fields of pharmaceutical, medical, or preclinical research; computer software for predicting cellular bioenergetics response to a drug or chemical for use in the fields of pharmaceutical, medical, or preclinical research

Computer software, namely, computer software for Quantitative Structure-Activity Relationship (QSAR) modeling of Absorption, Distribution, Metabolism, Elimination, and Toxicity (ADMET) properties; computer software which provides estimates of over 140 Absorption, Distribution, Metabolism, Elimination, and Toxicity (ADMET) properties; computer software which allows building Quantitative Structure-Property Relationships (QSAR/QSPR) models using in-house and public data sources with a proprietary software program; computer software with an interface that allows one to manipulate and visualize data; computer software which allows for the clustering of compound libraries based upon shared scaffolds; computer software which allows for the generation of virtual compound libraries; computer software which allows for creation of custom rules for risk assessment; computer software which generates the maximum common substructure between two or more structures; computer software which generates match molecular pair analysis; computer software that generates and uses fingerprints to analyze structures

INTERSTITIAL LUNG ISEASE SIMULATOR

Computer software for use in the fields of biomedical research and healthcare, namely, customizable software designed for use by biopharmaceutical companies to simulate individuals with variability in one or more patient characteristics such as drug metabolism, drug distribution, and drug effects, in developing a simulated patient population for the purpose of predicting and recommending options available for drug development based on outcomes observed from the simulated patients and simulated patient population

Scientific research and consultations services in the fields of research and development of compounds such as drugs or chemicals for others, including conducting simulations of compounds to evaluate and model their effects on non-alcoholic fatty liver disease (NAFLD)

Providing an in-person educational forum in the field of scientific research software application; Education services, namely, providing non-downloadable webinars in the field of scientific research software application; Educational services, namely, providing online instruction in the field of scientific research software application via an online website

The mark consists of an "S" and a "+" incorporated as elements in a shaded cube design.

Scientific research and consultations services in the field of research and development of drugs or chemicals for others, including conducting simulations of drug-liver interactions, and designing computer software for others to use in modeling liver responses to a drug or chemical

IPF SYM

Computer software, namely, downloadable computer software for modeling kidney response to a drug or chemical; downloadable computer software for conducting simulations of kidney interactions with a drug or chemical; downloadable computer software for predicting pharmacokinetic, pharmacodynamic, and kidney responses to a drug or chemical